oxaliplatin

Open Access
Initial Safety Analysis of CapeOx for Elderly Patients With Advanced Gastric Cancer Patients: A Phase II Trial
KEISHO CHIN, DAISUKE TAKAHARI, RYOHEI KAWABATA, HISASHI HOSAKA, SO SAITOU, TAKESHI SHIRAISHI, HIROSHI YABUSAKI, MASAHIRO GOTO, MASATO NAKAMURA, HIROSHI IMAMURA, YOSHIAKI SHINDO, FUMIO NAGASHIMA, WATARU ICHIKAWA, TAKASHI SAOTOME, WATARU YAMAMOTO, NAOKI ISHIZUKA and KENSEI YAMAGUCHI

Anticancer Research May 2022, 42 (5) 2683-2687; DOI: https://doi.org/10.21873/anticanres.15746
You have access
CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer
JUN KI HONG, DO YEON KIM, JAE-SIK SHIN, YEA SEONG RYU, JAI-HEE MOON, DONG-IN KOH, SEUL LEE, JINWOO LEE, WON JUN LEE, EUN YOUNG LEE, SOO-A JUNG, SEUNG CHAN KIM, HA NA YU, MI JIN KIM, SEUNG-WOO HONG, SANG SOO PARK, JOONYEE JUNG, SEUNG MI KIM, EUN HO KIM, HONG-RAE JEONG, JI HEE GONG, JIEUN KIM, TAE WON KIM and DONG-HOON JIN

Anticancer Research April 2022, 42 (4) 1813-1819; DOI: https://doi.org/10.21873/anticanres.15657
You have access
A Phase II Study of Dose-reductive XELOX Plus Bevacizumab in Elderly or Vulnerable Patients With Metastatic Colorectal Cancer (MCSGO-1202)
AYA KATO, NORIKATSU MIYOSHI, TORU OHTSURU, DAISUKE SAKAI, JUNICHI HASEGAWA, KEN NAKATA, MITSUNOBU IMASATO, TAKESHI KATO, MASAKAZU IKENAGA, TOSHIHIRO KUDO, MITSUYOSHI TEI, YOSHINORI KAGAWA, MAMORU UEMURA, HIDEKAZU TAKAHASHI, TAROH SATOH, MASAKI MORI, TSUNEKAZU MIZUSHIMA, HIROFUMI YAMAMOTO, KOHEI MURATA, YUICHIRO DOKI and HIDETOSHI EGUCHI

Anticancer Research April 2022, 42 (4) 1859-1865; DOI: https://doi.org/10.21873/anticanres.15662
You have access
Intensified Total Neoadjuvant Therapy Versus Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching Analysis
FRANCESCA DE FELICE, DANIELA MUSIO, FRANCO IAFRATE, SALVATORE CAPONNETTO, VINCENZO PICONE, GIANCARLO D’AMBROSIO, FABIO MASSIMO MAGLIOCCA, FRANCESCA TOZZI, GIORGIO DE TOMA, VINCENZO TOMBOLINI and ENRICO CORTESI

Anticancer Research February 2022, 42 (2) 991-1000; DOI: https://doi.org/10.21873/anticanres.15559
You have access
Perioperative FOLFOX in Patients With Locally Advanced Oesogastric Adenocarcinoma
STANISLAS QUESADA, EMMANUELLE SAMALIN, SIMON THEZENAS, LAKHDAR KHELLAF, ANNE MOURREGOT, FABIENNE PORTALES, THIBAULT MAZARD, MARC YCHOU and ANTOINE ADENIS

Anticancer Research January 2022, 42 (1) 185-193; DOI: https://doi.org/10.21873/anticanres.15472
You have access
Efficacy of FOLFOX Chemotherapy in Metastatic Enteropancreatic Neuroendocrine Tumors
SANDRINE OZIEL-TAIEB, CHRISTOPHE ZEMMOUR, JEAN-LUC RAOUL, LAURENT MINEUR, FLORA POIZAT, NATHALIE CHARRIER, GILLES PIANA, GERARD CAVAGLIONE and PATRICIA NICCOLI

Anticancer Research April 2021, 41 (4) 2071-2078; DOI: https://doi.org/10.21873/anticanres.14977
You have access
Comparison of Sinusoidal Obstruction Syndrome in Gastric Cancer Patients Receiving S-1/oxaliplatin Versus Capecitabine/oxaliplatin
EO JIN KIM, MOONHO KIM, SEYOUNG SEO, MI-JUNG KIM, MIN JU KIM and SOOK RYUN PARK

Anticancer Research January 2021, 41 (1) 391-402; DOI: https://doi.org/10.21873/anticanres.14788
You have access
Spleen Volume as a Predictive Biomarker for Thrombocytopenia and Liver Dysfunction After Oxaliplatin-based Chemotherapy
TAKASHI MIYATA, HIROYUKI TAKAMURA, RYOSUKE KIN, HISASHI NISHIKI, AKIFUMI HASHIMOTO, YORITAKA FUJII, SEIKO MIURA, JUN FUJITA, DAISUKE KAIDA, YASUTO TOMITA, NAOHIKO NAKAMURA, HIDETO FUJITA, SHINICHI KINAMI, NOBUHIKO UEDA and TAKEO KOSAKA

Anticancer Research June 2020, 40 (6) 3361-3370; DOI: https://doi.org/10.21873/anticanres.14319
You have access
Pegylated Liposomal Doxorubicin/Oxaliplatin Chemotherapy Can Overcome Cisplatin Resistance in Spectrin αII-Overexpressing Ovarian Carcinoma
OSAMU MAEDA, HIROAKI KAJIYAMA, KIYOSUMI SHIBATA, SHIGEO NAKAMURA and FUMITAKA KIKKAWA

Anticancer Research May 2020, 40 (5) 2497-2507; DOI: https://doi.org/10.21873/anticanres.14220
You have access
Postoperative Exacerbation of Oxaliplatin-induced Neurotoxicity in Gastrointestinal Cancers: A Case Series
AMALIA GONZALEZ, EVAN J. WALKER, KATHERINE VAN LOON, PELIN CINAR and CHLOE E. ATREYA

Anticancer Research February 2020, 40 (2) 865-871; DOI: https://doi.org/10.21873/anticanres.14019

Main menu

User menu

Search

oxaliplatin

Pages